MiMedx Group, Inc. announced on December 17, 2024, that it has filed a patent infringement lawsuit against Surgenex, LLC in the United States District Court for the District of Arizona. The lawsuit alleges that several of Surgenex’s placental allograft products infringe upon MiMedx’s patents.
The company is seeking permanent injunctive relief and monetary damages as a result of the alleged infringement. This legal action underscores MiMedx's commitment to defending its extensive intellectual property catalog for its leading placental allografts.
Protecting its patented PURION process and product formulations is vital for MiMedx to maintain its differentiated position and competitive edge in the advanced wound care and surgical sectors.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.